CCT8: A protein involved in cell death and tissue regulation (G10694)
CCT8: A protein involved in cell death and tissue regulation
CCT8 (Tcaspase-8) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a key player in the regulation of cell death and has been implicated in a number of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.
One of the key functions of CCT8 is its role in cell death, which is a critical process that removes damaged or dysfunctional cells from the body. When cells die, they can contribute to the development of diseases, such as neurodegenerative disorders, cancer, and autoimmune diseases.
In addition to its role in cell death, CCT8 has also been shown to play a key role in the regulation of cell growth and the development of tissues. It has been shown to promote the growth and development of various tissues, including brain, heart, and lungs.
CCT8 has also been shown to play a key role in the regulation of inflammation and immune responses. It has been shown to contribute to the regulation of inflammation and the immune response, which are critical for maintaining the health and integrity of the body.
Given its multiple functions and its involvement in a number of diseases, CCT8 has generated a lot of interest among researchers as a potential drug target or biomarker. Many studies have been conducted to investigate the potential therapeutic benefits of targeting CCT8, with a focus on its role in neurodegenerative disorders, cancer, and autoimmune diseases.
One of the main challenges in targeting CCT8 is its relatively small size and its location in the body. Despite its small size, CCT8 has a large number of interacting proteins and has been shown to play a key role in the regulation of a wide range of physiological processes.
In addition, CCT8 is also a protein that is expressed in many different tissues throughout the body, making it difficult to target it with small molecules or antibodies. However, researchers have been able to develop some compounds that are able to selectively target CCT8 and are being investigated as potential drug candidates.
Another challenge in targeting CCT8 is its role in cell death and its involvement in a number of processes that are difficult to study. For example, it is not clear how CCT8 contributes to cell death or how it interacts with other proteins that are involved in cell death.
Despite these challenges, research into the potential therapeutic benefits of targeting CCT8 is still in its early stages. However, it is clear that CCT8 is a protein that plays a critical role in the regulation of cell death and has a wide range of potential applications as a drug target or biomarker.
In conclusion, CCT8 is a protein that is expressed in various tissues throughout the body and plays a key role in the regulation of cell death and the development of tissues. It has also been shown to contribute to the regulation of inflammation and the immune response. Given its multiple functions and its involvement in a number of diseases, CCT8 has generated a lot of interest among researchers as a potential drug target or biomarker. Further research is needed to fully understand its role and its potential therapeutic applications.
Protein Name: Chaperonin Containing TCP1 Subunit 8
Functions: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis (PubMed:25467444). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). The TRiC complex plays a role in the folding of actin and tubulin (Probable)
The "CCT8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCT8 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2
